Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma

NCT00311467 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

172

Enrollment

OTHER

Sponsor class

Stopped no patient recruitment

Conditions

Renal Cell Cancer

Interventions

DRUG: Capecitabine, Interferon, Interleukin

Sponsor

Central European Cooperative Oncology Group